In addition to the aforedescribed finding, the statistical increase in the mRNA expression of E2F3 in fresh tumors compared to RB cell lines (p=0.01) discourages the use of RB cell lines to evaluate this gene for further studies. The gene discussed is E2F3; the disease is retinoblastoma.